The pharmacological action of kaempferol in central nervous system diseases: a review

J Silva dos Santos, JP Goncalves Cirino… - Frontiers in …, 2021 - frontiersin.org
Kaempferol (KPF) is a flavonoid antioxidant found in fruits and vegetables. Many studies
have described the beneficial effects of dietary KPF in reducing the risk of chronic diseases …

A review on Alzheimer's disease pathophysiology and its management: an update

A Kumar, A Singh - Pharmacological reports, 2015 - Elsevier
Alzheimer's disease acknowledged as progressive multifarious neurodegenerative disorder,
is the leading cause of dementia in late adult life. Pathologically it is characterized by …

Structure, synthesis, biosynthesis, and activity of the characteristic compounds from Ginkgo biloba L.

XG Liu, X Lu, W Gao, P Li, H Yang - Natural Product Reports, 2022 - pubs.rsc.org
Covering: 1928–2021 Ginkgo biloba L. is one of the most distinctive plants to have emerged
on earth and has no close living relatives. Owing to its phylogenetic divergence from other …

Alzheimer's disease: the challenge of the second century

DM Holtzman, JC Morris, AM Goate - Science translational medicine, 2011 - science.org
Alzheimer's disease (AD) was first described a little more than 100 years ago. It is the most
common cause of dementia with an estimated prevalence of 30 million people worldwide, a …

Combination drug therapy for the management of Alzheimer's disease

MT Kabir, MS Uddin, AA Mamun, P Jeandet… - International Journal of …, 2020 - mdpi.com
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Even though the
number of AD patients is rapidly growing, there is no effective treatment for this …

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

SM de la Monte - Current Alzheimer Research, 2012 - ingentaconnect.com
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite
30+ years of intense investigation, the field lacks consensus regarding the etiology and …

Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer's disease

B Shal, W Ding, H Ali, YS Kim, S Khan - Frontiers in pharmacology, 2018 - frontiersin.org
Alzheimer's disease (AD) is a chronic progressive neurodegenerative disorder associated
with dementia and cognitive impairment most common in elderly population. Various …

Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

R Leon, AG Garcia… - Medicinal research …, 2013 - Wiley Online Library
With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes
an overwhelming health, social, economic, and political problem to nations. Unless a new …

Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals

TA van Beek, P Montoro - Journal of chromatography A, 2009 - Elsevier
The chemical analysis and quality control of Ginkgo leaves, extracts, phytopharmaceuticals
and some herbal supplements is comprehensively reviewed. The review is an update of a …

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease

G Karthivashan, P Ganesan, SY Park, JS Kim… - Drug …, 2018 - Taylor & Francis
In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …